U
Unidad de Medicina Especializada SMA | San Juan del Rio, Queretaro
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Ertugliflozin
PF-04971729
Anastrozole
INO-4800
TOL2506
Tamoxifen
Exemestane
MK-8835
Letrozole
Leuprolide Acetate
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 5 total trials
This is a phase 3, single arm, open-label study evaluating the effectiveness of TOL2506 to suppress ovarian function in premenopausal women with HR+,...
Active, not recruiting
Breast Cancer
Drug: Anastrozole Tablets
Drug: Tamoxifen
Locations recently updated
TOL2506A (OVELIA) is a Phase 3, single arm, open-label study evaluating the effectiveness of TOL2506 in suppressing ovarian function in premenopausal...
Invitation-only
Breast Cancer
Drug: Exemestane Tablets
Drug: Anastrozole Tablets
Trial sponsors
T
C
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems